Catalog No.
YVV25303
Expression system
E. coli
Species
Dengue virus type 3 (strain Philippines/H87/1956) (DENV-3)
Protein length
Gly122-Arg205
Predicted molecular weight
37.67 kDa
Nature
Recombinant
Endotoxin level
Please contact with the lab for this information.
Purity
>90% as determined by SDS-PAGE.
Accession
P27915
Applications
ELISA, Immunogen, SDS-PAGE, WB, Bioactivity testing in progress
Form
Lyophilized
Storage buffer
Lyophilized from a solution in PBS pH 7.4, 0.02% NLS, 1mM EDTA, 4% Trehalose, 1% Mannitol.
Reconstitution
Reconstitute in sterile water for a stock solution. A copy of datasheet will be provided with the products, please refer to it for details.
Shipping
In general, proteins are provided as lyophilized powder/frozen liquid. They are shipped out with dry ice/blue ice unless customers require otherwise.
Stability and Storage
Use a manual defrost freezer and avoid repeated freeze thaw cycles. Store at 2 to 8°C for frequent use. Store at -20 to -80°C for twelve months from the date of receipt.
Alternative Names
Genome polyprotein, Protein prM, Precursor membrane protein (strain Philippines/H87/1956) (DENV-3)
Development of New Live-Attenuated Vaccine Candidates Lacking Antibody-Dependent Enhancement (ADE) Against Dengue., PMID:40432141
Structure-based identification of herbacetin and caffeic acid phenethyl ester as inhibitors of S-adenosylmethionine-dependent viral methyltransferase., PMID:40353321
Integrated serological surveillance for neglected tropical diseases, vaccine-preventable diseases, and arboviruses in Samoa, 2018., PMID:40221582
Understanding the factors impacting dengue rapid diagnosis in Bangladesh., PMID:40179512
Epidemiological and molecular typing of dengue viruses circulating in Jorhat district, Assam, India., PMID:40132676
Dengue dynamics in Bali: Serotype shifts, genotype replacement and multiple virus lineage circulation in the last 10 years., PMID:40008453
miRNome analysis reveals mir-155-5p as a protective factor to dengue infection in a resistant Thai cohort., PMID:39976655
Investigation of severe dengue outbreak in Maumere, East Nusa Tenggara, Indonesia: Clinical, serological, and virological features., PMID:39965014
RT-RPA Assisted CRISPR/Cas12a Based One-Pot Rapid and Visual Detection of the Pan-Dengue Virus., PMID:39949262
Comparison of clinical and virological features in pediatric and adult dengue cases at Insein General Hospital during Myanmar's 2022 dengue season., PMID:39881372
Simultaneous detection of dengue virus serotypes in a dual-serotype-detection nucleic acid based lateral flow assay., PMID:39798241
Trends in dengue virus positivity & serotyping in Rajasthan., PMID:39737514
Genetic diversity of dengue virus circulating in the Philippines (2014-2019) and comparison with dengue vaccine strains., PMID:39700304
All-Atom Perspective of the DENV-3 Methyltransferase Inhibition Mechanism., PMID:39639592
Dominance of dengue virus serotype-2 in Pakistan (2023-2024): Molecular characterization of the envelope gene and exploration of antiviral targets., PMID:39557198
Genetic and structural characterization of dengue virus involved in the 2023 autochthonous outbreaks in central Italy., PMID:39475407
Genomic surveillance reveals a dengue 2 virus epidemic lineage with a marked decrease in sensitivity to Mosnodenvir., PMID:39384752
Generation of dengue 3 envelope domain III using tobacco mosaic virus-based vector system and its immunological response mouse model by generating anti-dengue virus antibodies., PMID:39380277
Dengue fever as autochthonous infectious disease in Italy: Epidemiological, clinical and virological characteristics., PMID:39306188
Commercial Enzyme-Linked Immunosorbent Assay Kit Is Useful for Detection of Recombinant and Secretory Nonstructural-1 Protein Antigen of Dengue Virus., PMID:39134458
Efficacy and safety of Butantan-DV in participants aged 2-59 years through an extended follow-up: results from a double-blind, randomised, placebo-controlled, phase 3, multicentre trial in Brazil., PMID:39116904
Predominance of DENV-3 among patients in Ouagadougou, Burkina Faso., PMID:39113365
Impact of pre-existing cross-reactive antibodies on cyclic dengue outbreaks in the hyperendemic region of Bali, Indonesia., PMID:39089369
Estimating dengue burden among family contacts through cluster investigation around probable cases in 2022 and 2023 in the Central Region, Burkina Faso., PMID:38867325
mRNA-encoded Cas13 can be used to treat dengue infections in mice., PMID:38839984
Anti-inflammatory effect of Faloak (Sterculia quadrifida R. Br) stem bark on TNF-α, IL-1β, and IL-6 in DENV-3-infected Wistar rats., PMID:38808285
Circulating serotypes and genotypes of dengue virus in North India: An observational study., PMID:38648413
Low-dose dengue virus 3 human challenge model: a phase 1 open-label study., PMID:38561497
Dengue encephalopathy in an adult due to dengue virus type 1 infection., PMID:38491361
Prior dengue virus serotype 3 infection modulates subsequent plasmablast responses to Zika virus infection in rhesus macaques., PMID:38349142
Live, Attenuated, Tetravalent Butantan-Dengue Vaccine in Children and Adults., PMID:38294972
Homotypic antibodies target novel E glycoprotein domains after natural DENV 3 infection/vaccination., PMID:37909048
Neutralizing antibodies from prior exposure to dengue virus negatively correlate with viremia on re-infection., PMID:37857747
Safety and durable immunogenicity of the TV005 tetravalent dengue vaccine, across serotypes and age groups, in dengue-endemic Bangladesh: a randomised, controlled trial., PMID:37776876
Computational evaluation of quinones of Nigella sativa L. as potential inhibitor of dengue virus NS5 methyltransferase., PMID:37632317
Genetic Characterization of the Dengue Virus Type 3 Genotype I Prevailing in Dhaka, Bangladesh, 2021., PMID:37603293
Direct and indirect effects of age on dengue severity: The mediating role of secondary infection., PMID:37556473
A Phase 1, double-blind, randomized, placebo-controlled study to evaluate the safety and immunogenicity of a tetravalent live attenuated dengue vaccine in adults., PMID:37532611
Epitope prediction and designing of receptor inhibitor of Dengue Envelope Protein: An in silico approach., PMID:37417165
Experimental Dengue Virus Type 4 Infection Increases the Expression of MicroRNAs-15/16, Triggering a Caspase-Induced Apoptosis Pathway., PMID:37367040
Comparative phylogenetic analysis and transcriptomic profiling of Dengue (DENV-3 genotype I) outbreak in 2021 in Bangladesh., PMID:37337232
A tetravalent nanoparticle vaccine elicits a balanced and potent immune response against dengue viruses without inducing antibody-dependent enhancement., PMID:37275868
The Diagnostic Potential of RNA Aptamers against the NS1 Protein of Dengue Virus Serotype 2., PMID:37237536
Isolation and Genetic Evolution of Dengue Virus from the 2019 Outbreak in Xishuangbanna, Yunnan Province, China., PMID:37184906
Association of viral kinetics, infection history, NS1 protein with plasma leakage among Indonesian dengue infected patients., PMID:37130105
Evolutionary dynamics of dengue virus in India., PMID:37011104
S-Adenosyl-l-Homocysteine Exhibits Potential Antiviral Activity Against Dengue Virus Serotype-3 (DENV-3) in Bangladesh: A Viroinformatics-Based Approach., PMID:36873305
A Six Years (2010-2016) Longitudinal Survey of the Four Serotypes of Dengue Viruses in Lao PDR., PMID:36838207
Development of novel antiviral peptides against dengue serotypes 1-4., PMID:36739680
The dengue virus 4 component of NIAID's tetravalent TV003 vaccine drives its innate immune signature., PMID:36734144
For research use only. Not for human or drug use.
